Molecular oncology and targeted nanomedicine at the School of Medicine, Universidad Autónoma de Nuevo León (UANL), based at the Oncology Service of Hospital Universitario "Dr. José Eleuterio González" — Monterrey, México.
- MYC/MAX biology — competitive blockade strategies and downstream pathway profiling for oncogenic transcriptional programs.
- HER2+ targeted nanomedicine — receptor-guided delivery platforms (aptamer-coated AuNPs and polymeric NPs) carrying mRNAs, miRNAs, antimiRs, and peptide constructs.
- Post-GWAS functional annotation — reproducible pipelines for type 2 diabetes and metabolic loci (e.g., RPTOR/rs12950541).
- Breast cancer genetics in Northeastern Mexico — gene–environment interactions, ACMG/CAP variant interpretation.
- 🌐 Web biosketch: gallardo-lab.github.io
- 📜 ORCID: 0000-0002-7816-4967
- 🎓 Google Scholar: profile
- 🏛️ Institutional profile: UANL
- 🇲🇽 SNII directory: link
We welcome international collaborations on mechanism-driven cancer biology and translational nanomedicine.
Contact: hugo.gallardobl@uanl.edu.mx
Unless otherwise specified, code in this organization is released under the MIT License.-->